Chargement en cours...

The Use of Noncarbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase Infections

The continued rise in infections caused by extended-spectrum β-lactamase (ESBL)–producing pathogens is recognized globally as one of the most pressing concerns facing the healthcare community. Carbapenems are widely regarded as the antibiotics of choice for the treatment of ESBL-producing infections...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Infect Dis
Auteurs principaux: Tamma, Pranita D., Rodriguez-Baňo, Jesus
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5848369/
https://ncbi.nlm.nih.gov/pubmed/28362938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix034
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!